Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
05/2003
05/22/2003US20030096739 Nuclear receptor-mediated introduction of a PNA into cell nuclei
05/22/2003US20030096737 Caspase inhibitors and uses thereof
05/22/2003US20030096387 Contacting the isomerase with a compound having the structure: A-X-A, where A is radical which mimics the steric and electronic properties of phosphoserin and/or phosphothreonine residue, X= spacer, R is cyclic, heterocylic or aryl ring
05/22/2003US20030096350 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
05/22/2003US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof
05/22/2003US20030096029 Remedies for allergic diseases and process for producing the same
05/22/2003US20030096027 Alpha acid, (e.g., humulone) or beta acid (e.g., lupulone)
05/22/2003US20030096025 Oolong tea extract
05/22/2003US20030096023 Tyrosinase inhibitors from plants
05/22/2003US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/22/2003US20030095991 Treatment for skin
05/22/2003US20030095937 Method for stimulating hair growth by administering vitamin D analogs
05/22/2003CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2472019A1 Production of cell suspensions
05/22/2003CA2468497A1 Heterocyclic derivatives of glycinamide and their medical use
05/22/2003CA2467258A1 Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same and use of the same.
05/22/2003CA2467056A1 Carotenoid composition and method for protecting skin
05/22/2003CA2466790A1 Preventive or therapeutic agent for pruritus
05/22/2003CA2466519A1 Method for treating autoimmune diseases
05/22/2003CA2466465A1 Nk1 antagonists
05/22/2003CA2466440A1 Cannabinoid receptor ligands
05/22/2003CA2466055A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer
05/22/2003CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2464863A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
05/22/2003CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2464419A1 Benzimidazoles useful as protein kinase inhibitors
05/22/2003CA2464347A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2460959A1 Enzymes
05/21/2003EP1312675A1 Protein induced by homogeneous blood transfusion and dna encoding the same
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1312601A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
05/21/2003EP1312361A1 Antipruritic agent
05/21/2003EP1312360A1 Analgesic/antiinflammatory patches for topical use
05/21/2003EP1312356A1 Aqueous suspension preparations
05/21/2003EP1311657A2 Tissue engineering scaffolds promoting matrix protein production
05/21/2003EP1311534A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds
05/21/2003EP1311533A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311532A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311525A2 Composition and method for inhibiting platelet aggregation
05/21/2003EP1311522A1 New immunoeffector compounds
05/21/2003EP1311507A1 Fused pyrazole derivatives being protein kinase inhibitors
05/21/2003EP1311500A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity
05/21/2003EP1311498A1 Diamino phenothiazine derivatives and composition comprising same
05/21/2003EP1311489A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003EP1311478A1 Novel thiourea compounds and the pharmaceutical compositions containing the same
05/21/2003EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/21/2003EP1311290A2 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
05/21/2003EP1311288A1 Immunostimulatory nucleic acids for inducing a th2 immune response
05/21/2003EP1311287A2 Transglutaminase for inhibiting angiogenesis
05/21/2003EP1311270A1 Non-sedating barbiturate compounds as neuroprotective agents
05/21/2003EP1311263A2 Fused pyrrolocarbazoles against inflammation
05/21/2003EP1311259A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
05/21/2003EP1311255A1 Compounds having mif antagonist activity
05/21/2003EP1311252A2 Treatment of wounds
05/21/2003EP1311238A2 Cosmetic formulation containing at least one di-sugar alcohol phosphate of c3 to c6 sugar alcohols
05/21/2003EP1311237A2 Use of cyclic 2,4-diphosphoglycerates (cdgp) and/or derivatives thereof in cosmetic and dermatological formulations
05/21/2003EP1311236A1 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations
05/21/2003EP1311234A2 Substances for inducing and intensifying the tanning mechanisms of the skin
05/21/2003EP1189585B1 Cosmetic skin care compositions containing cumic alcohol
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003EP1023268B1 Isoquinolines as urokinase inhibitors
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003EP0835118B1 Utilization of sophorolipids for the preparation of cosmetic products, in particular for the treatment of the skin
05/21/2003EP0817625B1 Compositions for treatment of photodamaged skin comprising an rar-alpha antagonist and a multi-selective retinoid
05/21/2003EP0706394B1 Use of a compostion comprising histamine phosphate for the manufacture of a medicament for the topical treatment of epithelial inflammation or lesions
05/21/2003CN1419559A Tricyclic protein kinase inhibitors
05/21/2003CN1419552A 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors
05/21/2003CN1419548A 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1419453A Pharmaceutical gel composition
05/21/2003CN1419439A Compositions and methods for treating hair loss using oximyl-and hydroxylamino-prostaglandins
05/21/2003CN1419438A Cosmetic and pharmaceutical compositions and methods usin 2-decarboxy-2-phophinico derivatives
05/21/2003CN1419437A Compositions and method for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
05/21/2003CN1419435A Skin preparations for extenal use
05/21/2003CN1418685A Medicine composition for treating and its prepn. method
05/21/2003CN1418676A Drug topically applied for treating scald
05/21/2003CN1418674A Medicine compositions for treating acne, and its prepn. method
05/21/2003CN1418672A Capsule for treating psora
05/21/2003CN1418655A Aerosol for treating burn and scald, and its prepn-process
05/21/2003CN1418640A Exterior use prepn. for treating skin trauma
05/21/2003CN1418616A Cosmtics treatment using novel retinoid
05/21/2003CN1418615A Cosmetics contg. nucleic acid
05/21/2003CN1418611A Shampoo with functions of calvities-proof and hair-growth
05/21/2003CN1109106C Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them
05/21/2003CN1109031C Bicycle-aromatic compound
05/21/2003CN1108810C Medicine for treating psoriasis and preparing process thereof
05/21/2003CN1108809C Meidicine for treating leukoderma and preparing process thereof
05/21/2003CN1108807C Chinese herbs extract and preparation method and use thereof
05/21/2003CN1108805C Medicine for curing genital ulcer and dermatosis for external application
05/21/2003CN1108802C Pharmaceutical prescription for treating psoriasis
05/21/2003CN1108799C Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction
05/21/2003CN1108786C Siver foil cosmetics
05/20/2003WO2003044037A2 Process for the manufacture of human mononuclear phagocytic leukocytes
05/20/2003US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis
05/20/2003US6566405 Drugs, cosmetics or dietary supplements; immunomodulation, antiallergens (IgE mediated allergies, e.g., asthma, rhinitis, eczema); anaphylaxis; autoimmune disorders, e.g., Crohn's disease, antiarthritic and ulcer agents; analgesics
05/20/2003US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock
05/20/2003US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer
05/20/2003US6566363 5-amino-3-substituted-pyrazolo(4,5-d)thiazole compounds that mediate and/or inhibit the activity of cyclin-dependent kinases, useful for treating cancer, angiogenesis and cellular proliferation
1 ... 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 ... 1065